Amneal Pharmaceuticals (United States) holds 1 active US FDA Type II Drug Master File, has DMF or CEP filings on record for 1 active ingredient, holds 34 active Type IV (excipient) Drug Master Files and is linked to 3 FDA-registered manufacturing sites. 50 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Amneal Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/amneal-pharmaceuticals

Overview

Amneal Pharmaceuticals is a publicly traded company specializing in the development, manufacture, and distribution of generic and specialty pharmaceutical products. With a commitment to providing affordable medication, the company has established a broad portfolio addressing a wide range of therapeutic areas.

Core services & business areas

Generic PharmaceuticalsSpecialty PharmaceuticalsOver-the-Counter (OTC) MedicinesBiosimilarsDrug Manufacturing

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Amneal Pharmaceuticals holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Amneal Pharmaceuticals holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • GLATIRAMER ACETATEActive2013-12-12

Excipient Drug Master Files

Amneal Pharmaceuticals holds 34 active (34 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • NATURAL BANANA WONF FLAVOR UD-1190Active2020-07-20
  • NATURAL AND ARTIFICIAL MIXED FRUIT ENHANCER FLVP UA-7817Active2020-07-17
  • NATURAL AND ARTIFICIAL MIXED FRUIT FLVP FT 1789Active2017-04-07
  • NATURAL AND ARTIFICIAL ORANGE FLVP FLAVOR FZ-6607Active2016-12-02
  • NATURAL/ARTIFICIAL BERRY FLAVOR FY-6884Active2016-06-10
  • NATURAL/ARTIFICIAL ORANGE EXTRACT FLAVOR FZ-4297Active2016-06-10
  • ARTIFICIAL TUTTI FRUITTI FLVP FT-5103Active2016-06-10
  • NAT. MARASCHINO CHERRY TYPE CONCENTRATE FI FW-9004Active2013-12-18
  • ARTIFICIAL JUICY RASPBERRY FLAVOR FW-4870Active2013-07-08
  • ARTIFICAL CARAMEL FLAVOR FV-8873Active2013-02-13
  • ARTIFICIAL BANANA FLVP FT-8072Active2013-02-13
  • NAT/ART CREME DE VANILLA FLVP FT-8073Active2013-02-13
  • N/A CHERRY FLAVOR FV-7379Active2012-10-16
  • NATURAL ORANGE WONF FLAVOR FU-6556Active2011-10-12
  • N/A FRUIT TOPNOTE FLAVOR FU-6558Active2011-10-12
  • NATURAL AND ARTIFICIAL CHERRY FLVP FT-9496Active2011-07-26
  • NATURAL AND ARTIFICIAL BUBBLEGUM FLAVOR FU-3869Active2011-05-12
  • NATURAL AND ARTIFICIAL LEMON LIME FLVP FT-867Active2011-04-27
  • ARTIFICIAL GRAPE FLAVOR FT - 2968Active2011-02-16
  • NATURAL AND ARTIFICIAL YELLOW PLUM LEMON FLAVOR FT-5399Active2010-12-06
  • NATURAL AND ARTIFICIAL ORANGE FLVP FO-9464Active2010-06-09
  • NATURAL PEPPERMINT FLAVOR FT-3494Active2010-04-23
  • NATURAL CITRUS WONF FLAVOR FT-2811Active2010-04-23
  • NATURAL AND ARTIFICIAL STRAWBERRY ANISE FLAVOR FS-5206Active2010-03-26
  • ARTIFICIAL TUTTI FRUITTI FLAVOR FS-6943Active2010-01-20
  • ARTIFICIAL GRAPE FLAVOR FN-5393Active2008-05-14
  • N/A PINEAPPLE FLAVOR FM-4130Active2006-08-16
  • ART. STRAWBERRY FLAVOR FO-1022Active2006-07-31
  • N/A COUGH SYRUP MASKER FLAVOR FN-6819Active2006-07-31
  • N/A FRUIT FLAVOR FN-6714Active2006-04-12

Showing 30 of 34 excipient filings, active first.

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Amneal Pharmaceuticals, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

50 FDA enforcement records linked to this company.

  • recall — Class II2026-10-07

    Defective Container; packets were found to be either empty or partially full.

  • recall — Class III2026-06-17

    Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.

  • recall — Class I2026-04-08

    Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.

  • recall — Class II2026-04-08

    Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).

  • recall — Class II2025-09-10

    Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

  • recall — Class II2025-09-10

    Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

  • recall — Class II2025-09-10

    Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

  • recall — Class II2025-09-10

    Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

  • recall — Class II2025-09-10

    Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

  • warning_letter2025-08-27

    FDA Warning Letter (drug product)

  • recall — Class I2025-06-18

    Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.

  • recall — Class I2025-05-14

    Presence of Particulate Matter

  • recall — Class III2024-08-14

    Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.

  • recall — Class II2019-12-18

    CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

  • recall — Class II2019-12-18

    CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

  • recall — Class II2019-12-18

    CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

  • recall — Class II2019-12-18

    CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

  • recall — Class II2019-12-18

    CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

  • recall — Class III2019-11-20

    Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.

  • recall — Class III2019-10-16

    Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle

  • recall — Class III2019-07-31

    Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets

  • recall — Class III2019-07-10

    Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.

  • recall — Class III2019-07-10

    Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.

  • 4832019-05-24

    Habits of good sanitation & health

  • 4832019-05-24

    Failure to meet specifications

  • 4832019-02-21

    Reports of Analysis (Components)

  • 4832019-02-21

    Investigations of discrepancies, failures

  • 4832019-02-21

    Incoming material area

  • recall — Class II2018-04-04

    Presence of particulate matter

  • recall — Class II2017-11-22

    Presence of Particulate Matter

  • 4832017-10-25

    Calibration/Inspection/Checking not done

  • 4832017-10-25

    Written procedures not established/followed

  • 4832017-10-25

    Sanitation--buildings not clean, free of infestation

  • 4832017-10-25

    Procedures not in writing, fully followed

  • 4832017-10-25

    Cleaning SOP/inspection

  • 4832017-05-24

    Cleaning SOPs/equipment protection

  • 4832017-05-24

    Calibration/Inspection/Checking not done

  • 4832017-05-24

    Control procedures to monitor and validate performance

  • recall — Class II2017-05-10

    Failed Dissolution Specifications

  • 4832013-11-13

    Failure to meet specifications

  • 4832013-07-03

    Written procedures not established/followed

  • 4832013-07-03

    Establishment of time limitations

  • 4832013-07-03

    Procedures not in writing, fully followed

  • 4832010-05-26

    Failure to meet specifications

  • 4832010-05-26

    Investigations of discrepancies, failures

  • 4832008-11-10

    Investigations of discrepancies, failures

  • 4832008-11-10

    Calibration - at intervals, written program, remedial action

  • 4832008-11-10

    Procedures not in writing, fully followed

  • 4832008-11-10

    Failing drug products not rejected

  • 4832008-11-10

    Written procedures not established/followed

For suppliers

Is this Amneal Pharmaceuticals?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.